TrialBMC infectious diseases2017

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.

Eva van Doorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.